NASDAQ:MGTX MeiraGTx (MGTX) Stock Price, News & Analysis $8.57 -0.32 (-3.60%) Closing price 07/15/2025 04:00 PM EasternExtended Trading$8.60 +0.03 (+0.35%) As of 07/15/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock About MeiraGTx Stock (NASDAQ:MGTX) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get MeiraGTx alerts:Sign Up Key Stats Today's Range$8.48▼$8.9850-Day Range$4.64▼$8.8952-Week Range$3.85▼$8.98Volume334,105 shsAverage Volume407,209 shsMarket Capitalization$688.69 millionP/E RatioN/ADividend YieldN/APrice Target$24.00Consensus RatingBuy Company Overview MeiraGTx is a clinical-stage gene therapy company dedicated to discovering, developing and commercializing novel treatments for patients with severe inherited and acquired diseases. The company’s expertise spans vector design, novel gene therapy constructs and scalable manufacturing, with the goal of delivering durable, one-time treatments that address the underlying genetic causes of disease rather than merely managing symptoms. The company’s pipeline includes programs in ophthalmology, targeting inherited retinal diseases such as retinitis pigmentosa and Leber congenital amaurosis, as well as regenerative medicine and neuroscience indications. In addition to its vision-focused candidates, MeiraGTx is advancing gene therapy approaches for chronic pain and gastrointestinal disorders. These programs leverage both adeno-associated virus (AAV) platforms and mRNA delivery technologies to achieve sustained therapeutic benefit. Headquartered in London, U.K., and Cambridge, Massachusetts, MeiraGTx operates cGMP-compliant manufacturing facilities in both regions, supporting both early-stage research and late-stage clinical production. The company was founded in 2015 and began trading publicly on the NASDAQ stock exchange under the symbol MGTX in 2019. MeiraGTx collaborates with academic institutions and clinical centers around the world to conduct its trials and expand access to its investigational therapies.AI Generated. May Contain Errors. Read More MeiraGTx Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks85th Percentile Overall ScoreMGTX MarketRank™: MeiraGTx scored higher than 85% of companies evaluated by MarketBeat, and ranked 161st out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingMeiraGTx has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageMeiraGTx has only been the subject of 1 research reports in the past 90 days.Read more about MeiraGTx's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for MeiraGTx are expected to grow in the coming year, from ($1.48) to $0.38 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of MeiraGTx is -3.69, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of MeiraGTx is -3.69, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioMeiraGTx has a P/B Ratio of 9.85. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about MeiraGTx's valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted5.02% of the float of MeiraGTx has been sold short.Short Interest Ratio / Days to CoverMeiraGTx has a short interest ratio ("days to cover") of 6.5.Change versus previous monthShort interest in MeiraGTx has recently increased by 1.63%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldMeiraGTx does not currently pay a dividend.Dividend GrowthMeiraGTx does not have a long track record of dividend growth. Sustainability and ESG4.8 / 5Environmental Score-0.54 Percentage of Shares Shorted5.02% of the float of MeiraGTx has been sold short.Short Interest Ratio / Days to CoverMeiraGTx has a short interest ratio ("days to cover") of 6.5.Change versus previous monthShort interest in MeiraGTx has recently increased by 1.63%, indicating that investor sentiment is decreasing. News and Social Media3.2 / 5News Sentiment0.85 News SentimentMeiraGTx has a news sentiment score of 0.85. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.97 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for MeiraGTx this week, compared to 2 articles on an average week.Search Interest7 people have searched for MGTX on MarketBeat in the last 30 days. This is an increase of 600% compared to the previous 30 days.MarketBeat Follows2 people have added MeiraGTx to their MarketBeat watchlist in the last 30 days. Company Ownership2.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, MeiraGTx insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $522,575.00 in company stock.Percentage Held by InsidersOnly 7.50% of the stock of MeiraGTx is held by insiders.Percentage Held by Institutions67.48% of the stock of MeiraGTx is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about MeiraGTx's insider trading history. Receive MGTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MeiraGTx and its competitors with MarketBeat's FREE daily newsletter. Email Address MGTX Stock News HeadlinesMeiraGTx Holdings plc's (NASDAQ:MGTX) large institutional owners must be happy as stock continues to impress, up 25% over the past weekJuly 9, 2025 | finance.yahoo.comInsider Sell Alert: Alexandria Forbes Sells 47,500 Shares of MeiraGTx Holdings PLCJuly 8, 2025 | gurufocus.comWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. With gold at record highs and Bridgewater now buying in, one analyst believes Buffett’s next move could hit by August 15th. He’s identified the gold miner that fits Buffett’s profile — plus four smaller plays with even more upside. | Golden Portfolio (Ad)MeiraGTx (NASDAQ:MGTX) Upgraded by Wall Street Zen to Hold RatingJuly 6, 2025 | americanbankingnews.comMeiraGTx Holdings PLC News (MGTX) - Investing.comJuly 3, 2025 | investing.comMeiraGTx Holdings plc (MGTX) - Yahoo FinanceJuly 3, 2025 | finance.yahoo.comMeiraGTx Announces the Presentation of Four Posters at the American Society of Gene and Cell Therapy (ASGCT) 2025 Annual MeetingMay 13, 2025 | globenewswire.comMeiraGTx Reports First Quarter 2025 Financial and Operational ResultsMay 13, 2025 | globenewswire.comSee More Headlines MGTX Stock Analysis - Frequently Asked Questions How have MGTX shares performed this year? MeiraGTx's stock was trading at $6.09 at the beginning of the year. Since then, MGTX stock has increased by 40.7% and is now trading at $8.57. How were MeiraGTx's earnings last quarter? MeiraGTx Holdings PLC (NASDAQ:MGTX) posted its quarterly earnings data on Tuesday, May, 13th. The company reported ($0.51) earnings per share for the quarter, missing analysts' consensus estimates of ($0.38) by $0.13. The firm had revenue of $1.93 million for the quarter, compared to analysts' expectations of $4.44 million. MeiraGTx had a negative trailing twelve-month return on equity of 241.05% and a negative net margin of 484.90%. When did MeiraGTx IPO? MeiraGTx (MGTX) raised $75 million in an initial public offering (IPO) on Friday, June 8th 2018. The company issued 5,000,000 shares at $14.00-$16.00 per share. BofA Merrill Lynch, Barclays and Evercore ISI served as the underwriters for the IPO and Chardan was co-manager. How do I buy shares of MeiraGTx? Shares of MGTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of MeiraGTx own? Based on aggregate information from My MarketBeat watchlists, some other companies that MeiraGTx investors own include NVIDIA (NVDA), Tesla (TSLA), Advanced Micro Devices (AMD), Meta Platforms (META), Netflix (NFLX), JPMorgan Chase & Co. (JPM) and Moderna (MRNA). Company Calendar Last Earnings5/13/2025Today7/15/2025Next Earnings (Estimated)8/11/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - BIOMED/GENE Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:MGTX CIK1735438 Webwww.meiragtx.com Phone(646) 860-7985FaxN/AEmployees300Year FoundedN/APrice Target and Rating Average Price Target for MeiraGTx$24.00 High Price Target$35.00 Low Price Target$13.00 Potential Upside/Downside+180.0%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Trailing Twelve Months)($2.32) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$147.79 million Net Margins-484.90% Pretax Margin-484.90% Return on Equity-241.05% Return on Assets-62.93% Debt Debt-to-Equity Ratio2.34 Current Ratio1.53 Quick Ratio1.51 Sales & Book Value Annual Sales$33.28 million Price / Sales20.69 Cash FlowN/A Price / Cash FlowN/A Book Value$0.87 per share Price / Book9.85Miscellaneous Outstanding Shares80,360,000Free Float74,338,000Market Cap$688.69 million OptionableOptionable Beta1.24 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report This page (NASDAQ:MGTX) was last updated on 7/16/2025 by MarketBeat.com Staff From Our Partners3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhy Elon is funding the “Quantum Power Grid”Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MeiraGTx Holdings PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share MeiraGTx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.